查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2095006

體外震波碎石術市場：全球市場預測（2026-2032 年）

Extracorporeal Shock Wave Lithotripsy Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外震波碎石術 (ESWL) 市場將成長至 6.0268 億美元，複合年成長率為 6.69%。

主要市場統計數據
基準年（2025 年） 3.8292億美元
預計年份（2026年） 4.1024億美元
預測年份（2032年） 6.0268億美元
複合年成長率（） 6.69%

體外震波碎石術：執行摘要

體外震波碎石術（ESWL）仍然是治療尿道結石，特別是腎結石和上段輸尿管結石的重要非侵入性方法，其療效取決於結石的大小、位置、成分以及患者的解剖結構。此手術利用體外產生的聲波衝擊結石，將其擊碎成可排出的碎片，從而減少切口，並在許多醫療機構中實現當日出院。 ESWL的臨床應用與全球尿道結石METABOLIC INC.、反复尿道感染以及氣候相關的高溫暴露。目前的臨床實踐強調選擇合適的患者、基於影像學的結石特徵分析、考慮輻射暴露的工作流程以及術後隨訪，以確認結石排出並控制復發風險。隨著醫療保健系統優先考慮微創泌尿系統治療，體外震波碎石術 (ESWL) 繼續與輸尿管鏡檢查和經皮腎鏡取石術一起接受評估，評估依據包括結石清除率、再治療率、麻醉需求、併發症趨勢、患者偏好以及護理路徑的整體效率。

體外震波碎石術領域的變革性變化

體外震波碎石術（ESWL）領域正在經歷一場變革，其重點日益放在精準定位、以患者為中心的護理以及循證治療方案的選擇上。現代系統整合了超音波和透視引導，在提高結石定位準確性的同時，最大限度地減少了臨床醫生的輻射暴露。泌尿系統指引正在根據影響碎石成功率的因素（包括結石負荷、腎下極的解剖結構、結石與皮膚的距離、CT掃描顯示的結石密度以及估計的結石成分）來完善適應症標準。在實際操作中，ESWL 的應用範圍正在門診手術中心和醫院門診部不斷擴大，這些機構的保險報銷、熟練的醫護人員以及設備的配備都為高效的治療提供了支持。同時，對於某些類型的結石，由於輸尿管鏡檢查能夠即時進行可視化治療，並且在特定病例中具有較高的單次手術結石清除率，因此輸尿管鏡檢查正被優先考慮。這給 ESWL 機構帶來了壓力，要求其最佳化治療方案、減少再次治療，並更合理地選擇患者。因此，這種轉變並非背離體外震波碎石術，而是朝著更嚴格地使用非侵入性腎結石治療方法的方向發展，尤其是在該方法能夠帶來臨床和經濟上顯著益處的情況下。

人工智慧對體外震波碎石術的累積影響

人工智慧 (AI) 正在開始影響體外震波碎石術 (ESWL)，其作用並非取代臨床醫生的判斷，而是透過影響影像解讀、治療計畫和臨床決策支援來實現。 AI 驅動的影像工具可輔助電腦斷層掃描 (CT) 中結石的自動偵測、體積評估和亨氏單位 (HU) 值評估，指南對碎石潛力的估計和檢查方法的選擇。機器學習模型也正在被研究，以利用結石大小、位置、密度、結石與皮膚的距離、體重指數 (BMI)、腎臟病和結石形成史等變數來預測 ESWL 的成功率。在臨床實踐中，AI 驅動的標靶和運動校正技術可能有助於更好地控制呼吸運動並提高能量傳遞的一致性，但廣泛的臨床檢驗和與工作流程的整合仍然至關重要。除了手術本身，預測分析還可用於識別復發高風險患者，並在臨床適用的情況下，進行代謝評估、液體攝取指導、飲食調整和藥物預防措施。人工智慧的累積影響預計將在以下領域最為顯著：改善患者選擇、規範診斷影像的解讀、減少不必要的手術以及支持腎結石治療中可衡量的治療結果。

全球體外震波碎石術（ESWL）應用情況的區域分析。

亞太地區是體外震波碎石術（ESWL）的重點推廣區域。這是因為在人口稠密的國家，由於都市化、飲食鈉攝取量增加、糖尿病、肥胖以及炎熱氣候導致脫水風險上升，腎結石的發生率正在增加。在北美，完善的泌尿系統基礎設施、廣泛的電腦斷層掃描（CT）和超音波影像技術以及成熟的門診流程，支持ESWL繼續用於治療經適當篩選的結石，儘管臨床實踐擴大將ESWL的治療效果與輸尿管鏡檢查進行比較。在拉丁美洲，隨著專科醫療服務可近性的提高以及對經濟有效的微創治療的需求，ESWL的需求量增加，但主要城市醫院和醫療服務不足地區的ESWL服務水平可能存在差異。在歐洲，標準化的臨床指南、對輻射防護的高度重視以及將ESWL納入多方面泌尿系統診療框架的綜合碎石中心已經建立。在中東，由於炎熱的氣候、脫水風險以及碎石術帶來的負擔，ESWL的重要性依然不容忽視。先進的醫院正日益增加對非侵入性和內視鏡泌尿系統治療的投入。非洲的情況仍然不盡相同，體外震波碎石術（ESWL）主要集中在大型轉診機構。未來的發展機會將取決於診斷能力的提升、醫護人員培訓的加強、設備的維護以及更廣泛地提供安全的腎結石治療。

影響體外震波碎石術需求的主要群體構成分析。

在東南亞國協，體外震波碎石術（ESWL）的需求主要受都市區醫療體系擴張、私立醫院網路發展以及氣候條件增加結石復發風險等因素驅動，其中影像學和泌尿系統專家資源集中的地區ESWL應用最為廣泛。在海灣合作理事會（GCC）國家，高溫、脫水風險以及代謝性疾病的高發生率使得腎結石治療的臨床需求顯著增加，從而推動了對先進泌尿系統服務和門診治療模式的投資。在歐盟，醫療設備安全標準、臨床指引和輻射輻射計量管理等嚴格監管環境促進了ESWL在實證治療路徑中的系統性應用。在金磚國家，儘管患者數量龐大且醫療資源分配不均，但ESWL這種高度擴充性的非侵入性結石治療方法仍具有發展潛力，這也凸顯了其可負擔性、維護基礎設施和專家培訓的重要性。七國集團（G7）國家的特徵是泌尿系統網路高度發展、人口老化、先進影像技術廣泛應用，以及對體外震波碎石術（ESWL）與內視鏡治療療效的嚴格檢驗。北約成員國（其中許多與高所得醫療體系重疊）通常優先考慮完善的醫院基礎設施、技術驅動的醫療服務以及標準化的臨床實踐，這鼓勵在臨床適應症和保險報銷框架相符的情況下使用體外衝擊波碎石術。

針對各國體外震波碎石術治療路徑進行分析。

在美國，腎結石治療系統已相當完善，體外震波碎石術（ESWL）與輸尿管鏡檢查和經皮手術一起，在醫院和門診廣泛應用，其依據是臨床指南和保險公司的複治評估。在加拿大，由於強調循證專科護理和社區醫療保健系統的普及，ESWL 的可近性通常與醫院泌尿系統計畫掛鉤。在墨西哥和巴西，隨著都市區專科醫療服務的擴展，對微創結石治療的需求日益成長，但農村和資源匱乏地區仍然存在就醫難的問題。在英國、德國、法國、義大利和西班牙，ESWL 已納入基於指南的泌尿系統治療路徑，並得到影像學檢查、轉診網路以及以品質為導向的公共或混合醫療保健系統的支持。此外，德國和法國的專科醫療機構已實現了 ESWL 手術流程的顯著標準化。在俄羅斯，幅員遼闊的國土為醫療服務帶來了巨大挑戰，區域性的 ESWL 服務可近性和轉診系統對於獲得 ESWL 至關重要。在中國和印度，由於人口眾多、飲食結構改變以及許多地區氣候導致的脫水，腎結石已成為沉重的負擔。雖然大型醫院提供先進的結石治療方法，但能否更廣泛地獲得治療取決於設備和訓練有素的人員的配備。在日本和韓國，先進的影像技術、人口老化以及先進臨床技術的應用，促進了精準體外震波碎石術（ESWL）的應用。在澳大利亞，ESWL已納入完善的泌尿系統醫療體系，患者的居住地、轉診途徑以及能否前往區域專科中心等因素都會影響治療的實施。

為體外震波碎石術（ESWL）產業的領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的患者選擇工具，以提高體外震波碎石術 (ESWL) 的成功率並減少不必要的再次治療。投資於影像整合、超音波導引工作流程、劑量感知透視和使用者友善的標靶介面可以提高手術效率和安全性。醫療機構應制定標準化方案，涵蓋結石評估、鎮痛、能量逐漸增加、衝擊頻率監測、後續觀察影像檢查和復發預防諮詢。醫療設備製造商和服務合作夥伴應優先考慮正常運轉率、預防性保養、培訓和生命週期支持，尤其是在設備可靠性對可近性至關重要的領域。醫療機構可以透過將 ESWL 整合到包含代謝評估、營養指導、液體攝入指導和長期預防措施的多學科結石診療中心來改善治療效果。相關人員還應收集真實世界數據 (REW)，比較不同結石密度、位置、負荷和患者解剖特徵的 ESWL 療效，確保治療決策基於可衡量的臨床價值，而不僅僅是手術次數。

體外震波碎石術的深入分析方法

本報告基於二手研究途徑，數據來自公開、臨床可靠且符合監管要求的資訊來源。輸入資料包括泌尿系統指南、同儕審查的醫學文獻、關於尿道結石風險因素的公共衛生資料、醫療設備安全框架、醫院診療路徑文件以及區域醫療基礎設施指標。本分析不涉及市場規模計算、收入預測、市場佔有率排名和未來展望，而是專注於臨床應用促進因素、技術發展、區域可及性以及循證決策因素。透過對疾病負擔指標、治療指南建議、影像和治療標準以及醫療服務特徵進行三角驗證，整合了相關見解。報告重點強調了已驗證的主題，包括微創結石治療、體外震波碎石術（ESWL）患者選擇、人工智慧在醫學影像中的應用、門診泌尿系統工作流程、檢驗暴露減少以及腎結石復發預防。

結論：體外震波碎石術在現代膽結石治療中的作用

當結石特徵、患者解剖結構和臨床環境允許進行非侵入性碎石時，體外震波碎石術（ESWL）在腎結石治療中仍扮演重要角色。其未來的競爭力取決於精準的患者篩選、可靠的影像引導、最佳化的治療方案以及與更廣泛的結石預防策略的整合。人工智慧、先進的影像分析和標準化的門診工作流程可以透過改善治療計劃和減少治療差異來提升ESWL的價值。區域和國家層面的推廣應用將繼續取決於泌尿系統基礎設施、氣候相關的結石風險、保險報銷模式、設備取得以及訓練有素的專家的數量。醫療保健領導者的一項策略重點是將ESWL定位為實證尿道結石結石管理體系中一種高價值的選擇，而非萬能靈藥。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：人工智慧（AI）的累積影響（2026 年）

第7章：體外震波碎石術市場：依技術分類

  • 電液式
  • 電磁學
  • 壓電

第8章：體外震波碎石市場：依便攜性分類

  • 攜帶式的
  • 固定式

第9章：體外震波碎石市場：依治療模式分類

  • 住院治療
  • 門診

第10章：體外震波碎石市場：依應用領域分類

  • 膽結石
  • 腎結石
  • 輸尿管結石

第11章 體外震波碎石市場：依最終用戶分類

  • 門診手術中心
    • 獨立設施
    • 醫院設施
  • 診所
    • 多專科診所
    • 泌尿系統診所
  • 醫院
    • 私立醫院
    • 公立醫院

第12章：體外震波碎石市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：體外震波碎石市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 體外震波碎石術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）

第16章：公司簡介

  • Allengers Medical Systems
  • ARI Medical Technology Co., Ltd.
  • Dornier MedTech GmbH
  • EDAP TMS SA
  • ELMED Medical Systems
  • Elvation Medical
  • EMS Electro Medical Systems SA
  • GEMSS Co., Ltd.
  • Inceler Medikal Ltd.
  • Likamed GmbH
  • Medispec
  • MTS Medical AG
  • Nanjing Kapu Technology Co., Ltd.
  • Northern Litho, Inc.
  • Olympus Corporation
  • PT LUMINA PROCARE MEDITECH
  • Richard Wolf GmbH.
  • Shenzhen Hyde Medical Equipment
  • Shenzhen Wikkon Precision Technologies Co., Ltd.
  • Siemens Healthineers AG
  • Storz Medical AG
  • The Direx Group
  • United Medical Systems Inc.
  • Zimmer MedizinSysteme GmbH
Product Code: MRR-3A2E844FE771

The Extracorporeal Shock Wave Lithotripsy Market is projected to grow by USD 602.68 million at a CAGR of 6.69% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 382.92 million
Estimated Year [2026] USD 410.24 million
Forecast Year [2032] USD 602.68 million
CAGR (%) 6.69%

Extracorporeal Shock Wave Lithotripsy Executive Summary

Extracorporeal shock wave lithotripsy (ESWL) remains a cornerstone non-invasive treatment for urinary stone disease, particularly renal and upper ureteral calculi that are suitable by size, location, composition, and patient anatomy. The procedure uses externally generated acoustic shock waves focused on stones to fragment them into passable particles, reducing the need for incisions and supporting same-day care in many settings. Clinical adoption is closely tied to the global burden of urolithiasis, which is associated with low fluid intake, dehydration, dietary sodium intake, obesity, metabolic syndrome, recurrent urinary tract infections, and climate-related heat exposure. Current practice emphasizes appropriate patient selection, imaging-based stone characterization, radiation-conscious workflows, and post-procedure follow-up to confirm stone clearance and manage recurrence risk. As healthcare systems prioritize minimally invasive urology, ESWL continues to be evaluated alongside ureteroscopy and percutaneous nephrolithotomy based on stone-free outcomes, retreatment rates, anesthesia requirements, complication profiles, patient preference, and total care pathway efficiency.

Transformative Shifts in the ESWL Landscape

The ESWL landscape is being reshaped by a stronger focus on precision targeting, patient-centered care, and evidence-based procedure selection. Modern systems increasingly integrate ultrasound and fluoroscopic guidance to improve stone localization while helping clinicians limit radiation exposure where feasible. Urology guidelines continue to refine indications by stone burden, lower pole anatomy, skin-to-stone distance, stone density on computed tomography, and suspected composition, all of which influence fragmentation success. Operationally, ambulatory surgery centers and outpatient hospital departments are expanding the role of ESWL where reimbursement, trained staffing, and device access support efficient throughput. At the same time, ureteroscopy has gained preference for certain stone profiles due to immediate visual treatment and higher single-session clearance in selected cases, placing pressure on ESWL providers to demonstrate optimized protocols, reduced retreatment, and better patient stratification. The shift is therefore not away from ESWL, but toward more disciplined use in cases where non-invasive kidney stone treatment offers meaningful clinical and economic advantages.

Cumulative Impact of Artificial Intelligence on ESWL

Artificial intelligence is beginning to influence ESWL through image interpretation, treatment planning, and clinical decision support rather than replacing clinician judgment. AI-enabled imaging tools can support automated stone detection, volumetric assessment, and Hounsfield unit evaluation on computed tomography, helping estimate fragmentation likelihood and guide modality selection. Machine learning models are also being investigated to predict ESWL success using variables such as stone size, location, density, skin-to-stone distance, body mass index, hydronephrosis, and prior stone history. In procedural settings, AI-assisted targeting and motion-compensation concepts may help address respiratory movement and improve energy delivery consistency, although broad clinical validation and workflow integration remain essential. Beyond the procedure, predictive analytics can help identify patients at elevated risk of recurrence, prompting metabolic evaluation, hydration counseling, dietary modification, and pharmacologic prevention when clinically indicated. The cumulative impact of artificial intelligence is expected to be strongest where it improves patient selection, standardizes imaging interpretation, reduces avoidable procedures, and supports measurable outcomes in kidney stone management.

Key Regional Insights Across Global ESWL Adoption

Asia-Pacific is a high-priority region for ESWL because populous countries face rising kidney stone incidence linked to urbanization, dietary sodium intake, diabetes, obesity, and hot climates that increase dehydration risk. In North America, established urology infrastructure, broad access to computed tomography and ultrasound imaging, and mature outpatient care pathways support continued use of ESWL for appropriately selected stones, while clinical practice increasingly compares outcomes with ureteroscopy. Latin America shows demand tied to improving specialty care access and the need for cost-conscious, minimally invasive treatment, although availability may vary between major urban hospitals and underserved regions. Europe benefits from standardized clinical guidelines, strong emphasis on radiation protection, and integrated stone centers that use ESWL within a multimodal urology framework. The Middle East presents sustained procedural relevance due to hot weather, dehydration exposure, and a recognized stone disease burden, with advanced hospitals investing in non-invasive and endoscopic urology. Africa remains heterogeneous, with ESWL access concentrated in larger referral centers and opportunities linked to diagnostic capacity, workforce training, device maintenance, and broader access to safe kidney stone disease treatment.

Key Group Insights Shaping ESWL Demand

ASEAN demand for ESWL is influenced by growing urban healthcare capacity, expanding private hospital networks, and climatic conditions that can contribute to recurrent stone formation, with adoption strongest where imaging and urology specialist access are concentrated. GCC countries show a clear clinical need for kidney stone interventions due to heat exposure, dehydration risk, and high prevalence of metabolic conditions, supporting investment in advanced urology services and outpatient treatment models. The European Union provides a highly regulated environment shaped by device safety standards, clinical guideline adherence, and radiation-dose management, encouraging structured ESWL use within evidence-based care pathways. BRICS countries combine large patient populations with uneven healthcare access, creating opportunities for scalable non-invasive stone treatment while underscoring the importance of affordability, maintenance infrastructure, and specialist training. G7 countries are characterized by sophisticated urology networks, aging populations, advanced imaging availability, and strong scrutiny of comparative effectiveness between ESWL and endourological alternatives. NATO member countries, many of which overlap with high-income healthcare systems, generally emphasize resilient hospital infrastructure, technology-enabled care delivery, and standardized clinical practices, supporting ESWL use where clinical indications and reimbursement frameworks align.

Key Country Insights for ESWL Care Pathways

The United States has a well-established kidney stone treatment ecosystem, with ESWL used in hospitals and outpatient settings alongside ureteroscopy and percutaneous procedures, guided by clinical guidelines and payer scrutiny of repeat interventions. Canada emphasizes evidence-based specialty care and access through regional health systems, with ESWL availability often tied to hospital-based urology programs. Mexico and Brazil show increasing need for minimally invasive stone management as urban centers expand specialist services, while access gaps remain in rural and lower-resource areas. The United Kingdom, Germany, France, Italy, and Spain integrate ESWL within guideline-driven urology pathways, supported by diagnostic imaging, referral networks, and quality-focused public or mixed healthcare systems; Germany and France also demonstrate strong procedural standardization in specialist environments. Russia presents a large geographic care-delivery challenge, making regional availability and referral infrastructure important for ESWL access. China and India face substantial kidney stone burdens due to population scale, dietary transitions, and climate-related dehydration in many regions, with leading hospitals using advanced stone management while broader access depends on equipment distribution and trained personnel. Japan and South Korea combine advanced imaging, aging populations, and high clinical technology adoption, supporting precision-oriented ESWL use. Australia applies ESWL within a developed urology system where patient geography, referral pathways, and access to regional specialist centers influence treatment delivery.

Actionable Recommendations for ESWL Industry Leaders

Industry leaders should prioritize clinically validated patient-selection tools that improve ESWL success rates and reduce unnecessary retreatment. Investment in imaging integration, ultrasound-guided workflows, dose-conscious fluoroscopy, and user-friendly targeting interfaces can strengthen procedural efficiency and safety. Providers should develop standardized protocols covering stone assessment, analgesia, energy escalation, shock rate, follow-up imaging, and recurrence prevention counseling. Device manufacturers and service partners should emphasize uptime, preventive maintenance, training, and lifecycle support, particularly in regions where equipment reliability determines access. Healthcare organizations can improve outcomes by embedding ESWL into multidisciplinary stone clinics that include metabolic evaluation, nutrition guidance, hydration counseling, and long-term prevention. Stakeholders should also generate real-world evidence comparing ESWL outcomes by stone density, location, burden, and patient anatomy, ensuring that positioning remains grounded in measurable clinical value rather than procedure volume alone.

Research Methodology for ESWL Insights

This executive summary is developed using a secondary research approach grounded in publicly available, clinically credible, and regulatory-relevant sources. Inputs include urology association guidelines, peer-reviewed medical literature, public health data on urolithiasis risk factors, device safety frameworks, hospital care pathway documentation, and regional healthcare infrastructure indicators. The analysis excludes market sizing, revenue estimation, market share ranking, and forecasting, focusing instead on clinical adoption drivers, technology shifts, regional access patterns, and evidence-based decision factors. Insights are synthesized through triangulation of disease burden indicators, treatment guideline recommendations, imaging and procedural standards, and healthcare delivery characteristics. Emphasis is placed on verified themes such as minimally invasive stone treatment, ESWL patient selection, artificial intelligence in medical imaging, outpatient urology workflows, radiation reduction, and recurrence prevention in kidney stone disease.

Conclusion: ESWL's Role in Modern Stone Management

Extracorporeal shock wave lithotripsy continues to play an important role in kidney stone treatment where stone characteristics, patient anatomy, and care setting support non-invasive fragmentation. Its future competitiveness depends on precision selection, reliable imaging guidance, optimized treatment protocols, and integration with broader stone prevention strategies. Artificial intelligence, advanced imaging analytics, and standardized outpatient workflows can enhance the value of ESWL by improving procedural planning and reducing variability. Regional and country-level adoption will remain shaped by urology infrastructure, climate-related stone risk, reimbursement models, equipment access, and trained specialist availability. For healthcare leaders, the strategic priority is to position ESWL not as a universal solution, but as a high-value option within an evidence-based continuum of urinary stone disease management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Extracorporeal Shock Wave Lithotripsy Market, by Technology

  • 7.1. Introduction
  • 7.2. Electrohydraulic
  • 7.3. Electromagnetic
  • 7.4. Piezoelectric

8. Extracorporeal Shock Wave Lithotripsy Market, by Portability

  • 8.1. Introduction
  • 8.2. Mobile
  • 8.3. Stationary

9. Extracorporeal Shock Wave Lithotripsy Market, by Treatment Mode

  • 9.1. Introduction
  • 9.2. Inpatient
  • 9.3. Outpatient

10. Extracorporeal Shock Wave Lithotripsy Market, by Application

  • 10.1. Introduction
  • 10.2. Gallbladder Stones
  • 10.3. Renal Calculi
  • 10.4. Ureteral Calculi

11. Extracorporeal Shock Wave Lithotripsy Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
    • 11.2.1. Freestanding Centers
    • 11.2.2. Hospital Based Centers
  • 11.3. Clinics
    • 11.3.1. Multispecialty Clinics
    • 11.3.2. Urology Clinics
  • 11.4. Hospitals
    • 11.4.1. Private Hospitals
    • 11.4.2. Public Hospitals

12. Extracorporeal Shock Wave Lithotripsy Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Extracorporeal Shock Wave Lithotripsy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Extracorporeal Shock Wave Lithotripsy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Allengers Medical Systems
  • 16.2. ARI Medical Technology Co., Ltd.
  • 16.3. Dornier MedTech GmbH
  • 16.4. EDAP TMS SA
  • 16.5. ELMED Medical Systems
  • 16.6. Elvation Medical
  • 16.7. EMS Electro Medical Systems SA
  • 16.8. GEMSS Co., Ltd.
  • 16.9. Inceler Medikal Ltd.
  • 16.10. Likamed GmbH
  • 16.11. Medispec
  • 16.12. MTS Medical AG
  • 16.13. Nanjing Kapu Technology Co., Ltd.
  • 16.14. Northern Litho, Inc.
  • 16.15. Olympus Corporation
  • 16.16. PT LUMINA PROCARE MEDITECH
  • 16.17. Richard Wolf GmbH.
  • 16.18. Shenzhen Hyde Medical Equipment
  • 16.19. Shenzhen Wikkon Precision Technologies Co., Ltd.
  • 16.20. Siemens Healthineers AG
  • 16.21. Storz Medical AG
  • 16.22. The Direx Group
  • 16.23. United Medical Systems Inc.
  • 16.24. Zimmer MedizinSysteme GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ELECTROHYDRAULIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ELECTROHYDRAULIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ELECTROHYDRAULIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELECTROMAGNETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ELECTROMAGNETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELECTROMAGNETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PIEZOELECTRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PIEZOELECTRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PIEZOELECTRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MOBILE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MOBILE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MOBILE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GALLBLADDER STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GALLBLADDER STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GALLBLADDER STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RENAL CALCULI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RENAL CALCULI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RENAL CALCULI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL URETERAL CALCULI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL URETERAL CALCULI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL URETERAL CALCULI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOSPITAL BASED CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOSPITAL BASED CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOSPITAL BASED CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 133. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 138. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 160. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 174. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 188. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 189. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 192. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 197. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 198. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 201. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 202. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 206. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 207. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 221. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 224. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 225. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 228. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 229. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 233. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 234. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 237. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 238. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 242. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 243. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 246. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 247. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 248. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 251. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 255. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 256. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 260. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 261. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 264. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 265. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 275. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 278. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 279. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 282. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 283. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 284. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 286. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 287. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 288. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 291. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 292. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 293. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 296. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 297. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 300. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 301. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 302. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 305. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 306. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 309. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 310. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 311. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 312. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025